"ファイザー" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonOpinion | Pfizer Stopped Us From Getting Ozempic Decades Ago - The New York Times
Opinion | Pfizer Stopped Us From Getting Ozempic Decades Ago The New York Times
Better Income Stock: Pfizer or Altria Group? - Yahoo Finance
Better Income Stock: Pfizer or Altria Group? Yahoo Finance
Luigi Mangione's judge Katharine H Parker married to former executive of Pfizer: Reports - The Ti...
Luigi Mangione's judge Katharine H Parker married to former executive of Pfizer: Reports The Times of India
Pfizer Gets Enanta Patent Voided in Case Over Paxlovid Royalties - Bloomberg Law
Pfizer Gets Enanta Patent Voided in Case Over Paxlovid Royalties Bloomberg Law
Pfizer: Why I'm Staying On The Sidelines (NYSE:PFE) - Seeking Alpha
Pfizer: Why I'm Staying On The Sidelines (NYSE:PFE) Seeking Alpha
Better Income Stock: Pfizer or Altria Group? - The Motley Fool
Better Income Stock: Pfizer or Altria Group? The Motley Fool
Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Yahoo Finance
Judge in Luigi Mangione Case Married to Ex-Pfizer Executive, Owns Thousands in Healthcare Stock: ...
Who Is Katharine H. Parker? Luigi Mangione's Pre-Trial Judge Draws Attention For Marriage To Ex-P...
Is Pfizer Inc. (PFE) the Best Dividend Stock to Buy Under $50? - Yahoo Finance
Is Pfizer Inc. (PFE) the Best Dividend Stock to Buy Under $50? Yahoo Finance
Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance - Business Wire
Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance Business Wire
Pfizer Colleagues Celebrate Native American Heritage - Pfizer
Editor's Corner: The top 10 Fierce Pharma Marketing stories of 2024 recapped - FiercePharma
Editor's Corner: The top 10 Fierce Pharma Marketing stories of 2024 recapped FiercePharma
Pfizer does not expect major vaccine policy changes under Trump in 2025 - Reuters
Pfizer does not expect major vaccine policy changes under Trump in 2025 Reuters
BioRationality: A Critical Analysis of Pfizer Views on Sustainability of Biosimilars - The Center...
BioRationality: A Critical Analysis of Pfizer Views on Sustainability of Biosimilars The Center for Biosimilars
Is Pfizer Stock Undervalued? - Forbes
Is Pfizer Stock Undervalued? Forbes
Pfizer (NYSE:PFE) Stock Price Down 0.4% - What's Next? - MarketBeat
Pfizer (NYSE:PFE) Stock Price Down 0.4% - What's Next? MarketBeat
Pfizer Stock Rises as 2025 Outlook in Line With Expectations - Investopedia
Pfizer Stock Rises as 2025 Outlook in Line With Expectations Investopedia
Pfizer’s Braftovi regimen receives FDA accelerated approval to treat colorectal cancer - PMLiVE
Pfizer’s Braftovi regimen receives FDA accelerated approval to treat colorectal cancer PMLiVE
Comparing the COVID-19 Vaccines: How Are They Different? - Yale Medicine
Comparing the COVID-19 Vaccines: How Are They Different? Yale Medicine
Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years? - Yahoo Finance
Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years? Yahoo Finance
Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer - B...
Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer Business Wire
Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 - FiercePharma
Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 FiercePharma
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts -...
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts Business Wire
Should Value Investors Buy Pfizer (PFE) Stock? - Yahoo Finance
Should Value Investors Buy Pfizer (PFE) Stock? Yahoo Finance
Pfizer predicts stability, to Wall Street’s relief - BioPharma Dive
Pfizer predicts stability, to Wall Street’s relief BioPharma Dive
Pfizer’s Annual DEI Summit Focuses on Inclusion and Connection - Pfizer
Pfizer’s Annual DEI Summit Focuses on Inclusion and Connection Pfizer
Patrick Dempsey, Pfizer and the American Cancer Society Team Up to “Change the Odds” Against Canc...
Patrick Dempsey, Pfizer and the American Cancer Society Team Up to “Change the Odds” Against Cancer Pfizer
Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare - Pfizer
Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare Pfizer
Pfizer Just Reassured Investors, but Is the Stock a Buy? - The Motley Fool
Pfizer Just Reassured Investors, but Is the Stock a Buy? The Motley Fool
Pfizer School of Science Mobile Experience: Inspiring the Next Generation of Innovators - Pfizer
Pfizer School of Science Mobile Experience: Inspiring the Next Generation of Innovators Pfizer
Better Income Stock: Pfizer or Altria Group? - AOL
Is Pfizer Stock A Buy After Rallying On Its 2025 Guidance? - Investor's Business Daily
Is Pfizer Stock A Buy After Rallying On Its 2025 Guidance? Investor's Business Daily
Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and ...
Pfizer prevails in Enanta patent case over Covid-19 drug - Investing.com
Pfizer prevails in Enanta patent case over Covid-19 drug Investing.com
Tim Buckley Elected to Pfizer’s Board of Directors - Pfizer
Pfizer: Time And Patience Ran Out (Rating Downgrade) (NYSE:PFE) - Seeking Alpha
Pfizer: Time And Patience Ran Out (Rating Downgrade) (NYSE:PFE) Seeking Alpha
Pfizer’s colorectal cancer combo therapy gains accelerated approval from FDA - Yahoo Finance
Pfizer’s colorectal cancer combo therapy gains accelerated approval from FDA Yahoo Finance
Enanta Pharmaceuticals to Appeal Ruling in Patent Infringement Case Against Pfizer - MarketWatch
Enanta Pharmaceuticals to Appeal Ruling in Patent Infringement Case Against Pfizer MarketWatch
February 2025 Options Now Available For Pfizer (PFE) - Nasdaq
Pfizer’s In-Line Guidance Offers Relief to Weary Investors - Yahoo Finance
Pfizer’s In-Line Guidance Offers Relief to Weary Investors Yahoo Finance
Pfizer CEO says he developed 'good relation' with RFK Jr., highlights Trump's pride in vaccine wo...
Pfizer CEO says he developed 'good relation' with RFK Jr., highlights Trump's pride in vaccine work FiercePharma
Sickle cell disease drug's withdrawal leads to suits against Pfizer - San Francisco Business Time...
Sickle cell disease drug's withdrawal leads to suits against Pfizer - San Francisco Business Times The Business Journals
Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations - Yahoo Finance
Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Yahoo Finance
Pfizer’s 4th Latino Summit Champions Latino Representation - Pfizer
Pfizer’s 4th Latino Summit Champions Latino Representation Pfizer
Enanta stock slips as Pfizer wins Paxlovid patent (PFE:NYSE) - Seeking Alpha
Enanta stock slips as Pfizer wins Paxlovid patent (PFE:NYSE) Seeking Alpha
Health Insurers Fall as Pfizer CEO Says Trump Wants PBM Reform - Yahoo Finance
Health Insurers Fall as Pfizer CEO Says Trump Wants PBM Reform Yahoo Finance
Pfizer Inc. stock rises Tuesday, still underperforms market - MarketWatch
Pfizer Inc. stock rises Tuesday, still underperforms market MarketWatch
What Critics of Pfizer Are Getting Wrong - Yale Insights
What Critics of Pfizer Are Getting Wrong Yale Insights
Internship Spotlight: Miguel Agreda ’25, Pfizer - Yale School of Management
Internship Spotlight: Miguel Agreda ’25, Pfizer Yale School of Management
Pfizer’s year in review | Pfizer 2023 Annual Report - Pfizer
Pfizer answers Starboard challenge with beat-and-raise quarter - BioPharma Dive
Pfizer answers Starboard challenge with beat-and-raise quarter BioPharma Dive
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCET...
Accelerated approval brings Pfizer’s BRAF inhibitor to first-line patients - Endpoints News
Accelerated approval brings Pfizer’s BRAF inhibitor to first-line patients Endpoints News
Pfizer Wraps Up 8th Year of Immersive Girls Who Code Program - Pfizer
Pfizer Wraps Up 8th Year of Immersive Girls Who Code Program Pfizer
Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround - CNBC
Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC
Why Pfizer (PFE) Dipped More Than Broader Market Today - Yahoo Finance
Why Pfizer (PFE) Dipped More Than Broader Market Today Yahoo Finance
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? - Yahoo Finance
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Yahoo Finance
Pfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook - Investor's Business Daily
Pfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook Investor's Business Daily
Pfizer’s message to investors: The ship is steadying in 2025 (even if Washington is turbulent) - ...
Pfizer’s message to investors: The ship is steadying in 2025 (even if Washington is turbulent) Endpoints News
Playing catch-up with Pfizer and Roche, China-made ALK drug clears FDA in lung cancer - FiercePharma
Playing catch-up with Pfizer and Roche, China-made ALK drug clears FDA in lung cancer FiercePharma
Jim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the ...
Jim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the Stock Around? Yahoo Finance
Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism - Pfizer
Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism Pfizer
Pfizer Shares Jump 4% on Positive 2025 Outlook Despite $1B Impact - Yahoo Finance
Pfizer Shares Jump 4% on Positive 2025 Outlook Despite $1B Impact Yahoo Finance
New collaboration with Pfizer aimed at speeding drug discovery - WashU Medicine
New collaboration with Pfizer aimed at speeding drug discovery WashU Medicine
Pfizer's 2025 'Boring' Outlook Had A Nice Surprise That Was Overlooked - Seeking Alpha
Pfizer's 2025 'Boring' Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha
Exclusive: Pfizer explores sale of hospital drugs unit, sources say - Reuters
Exclusive: Pfizer explores sale of hospital drugs unit, sources say Reuters
Pfizer Sponsors Essence Festival for Third Consecutive Year - Pfizer
Pfizer Sponsors Essence Festival for Third Consecutive Year Pfizer
Pfizer Hires Schmidt College of Science Alumna Shilei Richards - Florida Atlantic University
Pfizer Hires Schmidt College of Science Alumna Shilei Richards Florida Atlantic University
Pfizer Works to Address Inequities in IBD Care - Pfizer
Pfizer Announces Layoffs in Tampa - Florida Daily
Pfizer Announces Layoffs in Tampa Florida Daily
Pfizer ($PFE) Stock Has Evolved Into a Solid Income Play - TipRanks
Pfizer ($PFE) Stock Has Evolved Into a Solid Income Play TipRanks
Pfizer (NYSE:PFE) Stock Price Up 0.1% - Here's Why - MarketBeat
Pfizer (NYSE:PFE) Stock Price Up 0.1% - Here's Why MarketBeat
Pfizer Announces Restrictions to Keep States From Using Its Medicines in Executions - Death Penal...
Pfizer Announces Restrictions to Keep States From Using Its Medicines in Executions Death Penalty Information Center
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Pati...
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction - Pfizer (NYSE...
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeut...
Pfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion - Yahoo Finance
Pfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion Yahoo Finance
You’ve never heard of the Covid booster with the fewest side effects - Vox.com
You’ve never heard of the Covid booster with the fewest side effects Vox.com
Pfizer's 2025 Outlook: Is This the Breakthrough Investors Have Been Waiting For? - Yahoo Finance
Pfizer's 2025 Outlook: Is This the Breakthrough Investors Have Been Waiting For? Yahoo Finance
Pfizer management looks to show turnaround as Starboard looms - Reuters
Pfizer management looks to show turnaround as Starboard looms Reuters
Pfizer (NYSE:PFE) Stock Price Down 0% - What's Next? - MarketBeat
Pfizer (NYSE:PFE) Stock Price Down 0% - What's Next? MarketBeat
Luigi Mangione Judge Married to Former Healthcare Exec - The Daily Beast
Luigi Mangione Judge Married to Former Healthcare Exec The Daily Beast
Pfizer Goes Live in SXSW’s Podcast Lounge - Pfizer
Use of the Pfizer Pentavalent Meningococcal Vaccine... - CDC
Uninhibited: Fostering Conversation Within the IBD Community - Pfizer
Uninhibited: Fostering Conversation Within the IBD Community Pfizer
Will Pfizer Beat Earnings In Q3? - Forbes
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure - Reuters.com
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure Reuters.com
Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting - Pfizer
Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting Pfizer
Pfizer (NYSE:PFE) Shares Down 0.2% - Here's What Happened - MarketBeat
Pfizer (NYSE:PFE) Shares Down 0.2% - Here's What Happened MarketBeat
Living Our Values Through Pfizer’s Refugee Initiatives - Pfizer
Living Our Values Through Pfizer’s Refugee Initiatives Pfizer
What’s Happening With PFE Stock? - Forbes
What's Happening With Pfizer Stock? - Forbes
Pfizer and SPH Continue to Promote Graduate Studies in Biostatistics - Boston University School o...
Pfizer and SPH Continue to Promote Graduate Studies in Biostatistics Boston University School of Public Health
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26...
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26? The Motley Fool
Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design - Pfizer
Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design Pfizer